AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2005
Mar 28, 2005
30339_dirs_2005-03-28_1b23b44c-d48d-4d43-ade3-dec495f82a46.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2005-03-24
Reporting Person: ALTEMUS LINDA R (VP & Chief Compliance Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2005-03-24 | Common stocks | A | 12.58 | $23.7100 | Acquired | 4231.7690 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stocks | 23411.3656 | Direct |
| Common stocks | 1382.5678 | Indirect |
Footnotes
F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27